Teleflex Incorporated 10-K Summary
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 26, 1999. Teleflex Incorporated is a diversified manufacturer operating in three primary segments: Commercial (automotive, marine, and industrial controls), Medical (invasive devices and surgical instruments), and Aerospace (cargo systems and turbine engine services). The company employs approximately 14,700 people and operates roughly 100 facilities globally. In 1999, sales distribution by market was 47% Commercial, 30% Aerospace, and 23% Medical.
Key Financial Metrics
The provided filing text incorporates the detailed financial statements by reference to the 1999 Annual Report to Shareholders and does not contain specific consolidated revenue, net income, cash flow, or debt figures. However, the following specific data points are available:
- Allowance for Doubtful Accounts: Ended the year at $4,825,000 (up from $4,577,000 in 1998).
- Bad Debt Charges: $1,613,000 charged to income for the year.
- Market Capitalization: Aggregate market value of non-affiliate voting stock was approximately $1.05 billion as of February 1, 2000.
- Shares Outstanding: 38,054,220 common shares as of February 1, 2000.
Material Changes and Backlog
Significant changes in order backlogs were reported for the year:
- Aerospace Segment: Backlog decreased from $418 million (1998) to $295 million (1999). Over half is expected to be filled in 2000.
- Commercial Segment: Backlog increased from $124 million to $144 million.
- Medical Segment: Backlog remained relatively stable, increasing slightly from $21 million to $22 million.
Management noted that medical and commercial backlogs are not indicative of future sales due to short delivery cycles.
Outlook, Risks, and Management Commentary
Strategic Initiatives: The company continues to utilize its "New Venture Fund," investing 0.5% of sales into new product development to foster innovation. Recent acquisitions in 1999 included Century Aero Products (Aerospace), Medical Sterilization, Inc., and Kmedic (Medical) to expand service capabilities and product lines.
Leadership Changes: Lennox K. Black replaced David S. Boyer as Chief Executive Officer on January 31, 2000.
Risks and Contingencies:
- Environmental: The company is named as a potentially responsible party at various EPA sites. Management does not expect environmental costs to be material to financial position.
- Competition: The company faces varying degrees of competition across all segments but relies on technical competence and engineering capabilities for its competitive edge.
- Patents: The business is not considered materially dependent on patent protection.
Investor Verification Checklist
- Verify consolidated revenue, net income, and cash flow figures in the 1999 Annual Report to Shareholders (incorporated by reference, pages 17-25).
- Review the "1999 Financial Review" (pages 26-31 of the Annual Report) for detailed margin analysis and liquidity metrics not present in this text.
- Confirm the impact of the CEO transition on strategic direction.
- Monitor the execution of the $295 million Aerospace backlog, which represents a significant portion of future revenue.
- Assess the integration of 1999 acquisitions (Century Aero, Medical Sterilization, Kmedic) for synergy realization.